A future-forward influenza immunization model of care for high-risk patients in pharmacies: A Canadian consensus

Can Pharm J (Ott). 2024 Jul 30;157(5):209-217. doi: 10.1177/17151635241263548. eCollection 2024 Sep-Oct.

Aaron Sihota¹, Cameron Bonell^{1

2}, Brittany Buffone³, Sherilyn K D Houle⁴, Michael Kani⁵, Josh Kim⁶, Erica MacLean⁷, Anas Nseir⁸, Pavithra Ravinatarajan⁹, Francis Richard¹⁰, Tiana Tilli^{1

1}, Carolyn Whiskin^{11

12

13}, Victor Wong¹⁴, Paul Roumeliotis¹⁵

¹ Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia.
² Interior Health Authority, University of British Columbia, Kelowna, British Columbia.
³ Lower Mainland Pharmacy Services, Fraser Health, Vancouver, British Columbia.
⁴ School of Pharmacy, University of Waterloo, Waterloo, Ontario.
⁵ PharmAssess Diagnostics and Custom Health, Calgary, Alberta.
⁶ London Drugs Limited, Richmond, British Columbia.
⁷ Nova Scotia Health, Victoria General Site, Halifax, Nova Scotia.
⁸ Family Medicine and Emergency Medicine Department, Université de Montréal, Montréal, Quebec.
⁹ Pavithra Consulting Inc., Mississauga, Ontario.
¹⁰ Faculté de pharmacie, Université de Montréal, Montréal, Québec.
¹¹ Charlton Health Inc., Hamilton, Ontario.
¹² Brant Arts Pharmacy, Burlington, Ontario.
¹³ University of Toronto, Toronto, Ontario.
¹⁴ Loblaw Companies Limited, Brampton, Ontario.
¹⁵ Eastern Ontario Health Unit, Cornwall, Ontario.

No abstract available